Why TransMedics Group, Inc. (TMDX) stock rose 27.9% on Friday, November 6, 2026

TransMedics Group, Inc. (TMDX) closed at $88.24, up 27.92% on Friday, November 6, 2026, on volume of 3,948,819 shares (4.9× its 3-month average); market value about $3.00B.

What happened: primary sources

Events Nexqual found for TMDX on Friday, November 6, 2026 or the trading day before (November 5, 2026):

• Nov 5, 2026: Reported Q3 2026 results: adjusted EPS $0.51 vs consensus $0.29 (beat), revenue $203.0M vs consensus $177.1M (beat). Guidance: Full-year 2026 revenue guidance raised to $764-$774 million, including PAD Aviation. source
• Nov 6, 2026: Needham: Target raised, Buy, price target $106 → $110
• Nov 6, 2026: Canaccord Genuity: Target raised, Buy, price target $95 → $120

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on TMDX

TMDX stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Earnings report: TMDX results, November 5, 2026. Other big moves that day: November 6, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:31 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 10, 2026 at 16:31 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt